医学
狼牙棒
生物标志物
内科学
弗雷明翰风险评分
心脏病学
风险评估
肿瘤科
疾病
十分位
肌钙蛋白
成像生物标志物
冠状动脉疾病
放射科
心脏成像
诊断准确性
试验预测值
年轻人
作者
Mendel Lebowitz,Gourav Modanwal,Amritpal Singh,Rohan Dhamdhere,S.G. Diwan,Taofik Ahmed Suleiman,Hilmi Al-Shakhshir,Michael Gilkey,Scott L. Shofer,Santosh Kumar Sirasapalli,Moore Benjamin Shoemaker,Sadeer G Al-Kindi,Sanjay Rajagopalan,Anant Madabhushi
标识
DOI:10.1093/eurheartj/ehag498
摘要
BACKGROUND AND AIMS: Chronological age is central to cardiovascular disease (CVD) risk estimation but poorly reflects interindividual heterogeneity in cardiovascular aging. This study developed a peri-aortic adipose tissue (PAAT) radiomic cardiovascular age (CV-Age) biomarker from routine chest CT and tested whether the PAAT age gap (ΔAge = CV-Age - chronological age) stratifies major adverse cardiovascular events (MACE) and improves risk classification. METHODS: Four chest CT cohorts with different protocols were utilized to train (n = 4451) and externally validate (n = 44 214) a CV-Age model. Associations between ΔAge decile groups (resilient ≤10th; accelerated ≥90th) and incident 5-point MACE (myocardial infarction, stroke, revascularization, heart failure, and death) were assessed using survival models. Clinical utility was evaluated by substituting CV-Age for chronological age in PREVENT to quantify risk reclassification. RESULTS: A 31-feature radiomic signature capturing PAAT volume, attenuation, and texture heterogeneity predicted age with good accuracy (training MAE 2.2 years; primary external validation MAE 2.7 years). In a separate higher-risk cohort, predictions showed a positive ΔAge (median +5.4 years), reflecting elevated baseline cardiovascular burden. ΔAge-stratified event-free survival differed across groups (log-rank P < .001); compared with normative agers, accelerated agers had higher MACE risk (HR 1.51, 95% CI 1.37-1.66), and resilient agers had lower risk (HR 0.70, 0.63-0.77). Substituting CV-Age into PREVENT improved risk reclassification (categorical NRI +0.03, P < .01, continuous NRI +0.04, P < .05). CONCLUSIONS: Radiomic profiling of PAAT on routine chest CT yields a scalable imaging biomarker of cardiovascular aging. CV-Age can help improve identification of higher-risk individuals missed by age-driven risk estimation, supporting its role as a risk-enrichment tool.
科研通智能强力驱动
Strongly Powered by AbleSci AI